- Global Pharma News & Resources

North America Orthobiologics Market Report Analysis And Insights For Highly Profitable Investment Decision: Industry Outlook By 2021-2028

North America orthobiologics market is registering a substantial CAGR of 6.58% in the forecast period of 2019-2026. This rise in the market value can be attributed to the surging orthopedic related diseases due to lifestyle choices and increased consciousness among individuals due to orthobiological advantages.

Orthobiologics can also be referred to as regenerative cellular therapies. Orthobiological products include development factors to enhance and stimulate the pain, tissue healing, and help in repairing ordinary functioning.

Major factors that are expected to boost the growth of the orthobiologics market in the forecast period are the rise in the prevalence of sports injuries and road accidents. Furthermore, the increase in the cases of spinal diseases and disorders is further anticipated to propel the growth of the orthobiologics market. Moreover, the increasing in the patient preference for minimally invasive procedures is further estimated to cushion the growth of the orthobiologics market. On the other hand, the rise in the cost regarding the orthobiologics-based treatments is further projected to impede the growth of the orthobiologics market in the timeline period.

Get a Sample Copy of the Report to comprehend the construction of the total report (Including Full TOC, Table, and Figures):

Major Market Key Competitors:

Few of the major market competitors currently working in the North America orthobiologics market are  Baxter, CONMED Corporation, DePuy Synthes, Exactech, Inc., Integra LifeSciences Corporation, Medtronic, NuVasive, Inc., RTI Surgical Holdings, Inc., Sanofi, Smith & Nephew, Stryker, Zimmer Biomet, SINTX Technologies, Inc., AlloSource, aap Implantate AG, and others.

Market Definition: North America Orthobiologics Market

Orthobiologics are drugs that are used by orthopedic surgeons to assist cure wounds faster. They are used to enhance regeneration of damaged joints and tissues, tendons and ligaments that have been wounded. These products are produced of normally occurring drugs in your flesh. Using orthobiologics drugs in greater levels helps speed up the healing process. Some main advantages connected with conservative orthobiologics therapies include minimizing the effect of degenerative disease, completing all processes as an outpatient in the workplace, and regeneration is faster than surgery.

Market Drivers

  • Growing old population, is driving the growth of the market
  • Surging orthopedic related diseases due to lifestyle choices, is propelling the growth of the market
  • Technological advancement in the orthobiologics,  is boosting the growth of the market
  • Increased consciousness among individuals due to orthobiological advantages, is contributing to the growth of the market

Market Restraints

  • Strict government guidelines, are restricting the growth of the market.
  • Post-surgery difficulties, is hindering the growth of the market
  • High charge of orthopedic implants, is hampering the growth of the market,

Get the Latest TOC Of This Report @

Segmentation: North America Orthobiologics Market


  • Demineralized bone matrix (DBM)
  • Allograft
  • Bone morphogenetic protein (BMP)
  • Viscosupplementation
  • Synthetic bone substitutes
  • Stem cell therapy
  • Bone Marrow Aspirate Protein
  • Plasma-Rich Protein
  • Other Products

By Application

  • Spinal fusion
  • Trauma repair
  • Reconstructive surgery
  • Tendon and ligament
  • Osteoarthritis and Degenerative Arthritis
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications
  • Others

By Type

  • Knee
  • Ankle
  • Hip
  • Wrist & Shoulder
  • Spine
  • Others

By End-User

  • Hospitals
  • Orthopedic clinics & Ambulatory Care Centers
  • Research & Academic Institutes
  • Dental Clinics and Facilities

By Country

  • U.S.
  • Canada
  • Mexico

Get More Information on this Research Report:

Key Offerings:

– Market Size and Forecast by Revenue | 2021−2028
– Market Dynamics – Leading patterns, development drivers, limitations, and venture openings
– Market Segmentation – An itemized examination by item, by types, end-client, applications, fragments, and geology
– Competitive Landscape – Top key sellers and other conspicuous vendorsInquire

 Key Developments in the Market:

  • In August 2019, SeaSpine Holdings Corporation has declared the restricted release and accomplishment of the primary operation of its Shoreline RT Cervical Interbody Implant System. Shoreline RT is the initial in a series of products to mix exclusive NanoMetalene technology with the Reef Topography. This system involves big footprint implants and various lordosis choices intended to allow surgeons to respond to a multitude of patient anatomies and pathologies.
  • In March 2019, Fidia is presenting NuDYN, its first item in the class of regenerative medicine. NuDYN is a stable, injectable, flow-proof amniotic membrane-derived allograft of donor placenta acquired through cesarean delivery. It is designed to be acellular to allow shelf-stable retention while maintaining the useful characteristics of the amniotic membrane including hyaluronic acid, collagen and development variables. These intrinsic characteristics of the allograft provide safety, lubrication and help.

Competitive Analysis:

North America orthobiologics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of orthobiologics market for North America.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of North America orthobiologics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Related Reports:
Global Orthobiologics Market – Industry Trends and Forecast to 2028
Europe Orthobiologics Market – Industry Trends and Forecast to 2026
Asia-Pacific Orthobiologics Market – Industry Trends and Forecast to 2026

About Data Bridge Market Research

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who rely on our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 13-Aug-2021